• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Turns Higher; GDS Holdings Shares Climb

    3/11/24 2:44:29 PM ET
    $DUO
    $ELTK
    $EQT
    $ETRN
    Real Estate
    Finance
    Electrical Products
    Technology
    Get the next $DUO alert in real time by email

    U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday.

    The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&P 500 also fell, dropping, 0.14% to 5,116.66.

    Check This Out: Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates 'A Winner'

     

    Leading and Lagging Sectors

     

    Materials shares jumped by 0.9% on Monday.

    In trading on Monday, industrials shares fell by 0.8%.

     

    Top Headline

     

    EQT Corporation (NYSE:EQT) announced that it entered into a definitive merger agreement to acquire Equitrans Midstream Corporation (NYSE:ETRN).

     

    Equities Trading UP

     

    GDS Holdings Limited (NASDAQ:GDS) shares shot up 22% to $7.80 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business.

    Shares of Fangdd Network Group Ltd. (NASDAQ:DUO) got a boost, surging 20% to $0.7234 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector

    Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares were also up, gaining 22% to $2.6550 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.

     

    Equities Trading DOWN

     

    Eltek Ltd. (NASDAQ:ELTK) shares dropped 22% to $10.80 after the company announced downbeat quarterly earnings.

    Shares of Genie Energy Ltd. (NYSE:GNE) were down 10% to $16.98 following fourth-quarter results.

    Ventyx Biosciences, Inc. (NASDAQ:VTYX) was down, falling 20% to $7.89. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.

    Also Check This Out: Top 5 Risk Off Stocks That May Plunge This Quarter

     

    Commodities

     

    In commodity news, oil traded down 0.2% to $77.84 while gold traded up 0.1% at $2,186.40.

    Silver traded up 0.6% to $24.69 on Monday while copper rose 0.9% to $3.9275.

     

    Euro zone

     

    European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.35%, London’s FTSE 100 rose 0.12% while Spain’s IBEX 35 Index rose 0.19% The German DAX fell 0.38% French CAC 40 fell 0.10% while Italy’s FTSE MIB Index fell 0.27%.

    Spanish retail trade rose by 0.3% year-over-year in January versus a revised 2.7% gain in the previous month.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Monday, with Japan’s Nikkei 225 dipping 2.19%, Hong Kong’s Hang Seng Index gaining 1.43%, China’s Shanghai Composite Index gaining 0.74% and India’s S&P BSE Sensex falling 0.81%.

    Chinese vehicle sales dipped by 19.9% year-over-year to 1.58 million units in February versus a 47.9% surge in the prior month. Japanese machine tool orders declined by 8% year-over-year to JPY 114,154 million in February. Japan's GDP expanded by 0.1% quarter-over-quarter in the fourth quarter versus a 0.8% contraction in the third quarter.

     

    Economics

     

    No economic report of significance is due for Monday

    Now Read This: How To Earn $500 A Month From Calavo Growers Ahead Of Q1 Earnings

    Get the next $DUO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DUO
    $ELTK
    $EQT
    $ETRN

    CompanyDatePrice TargetRatingAnalyst
    GDS Holdings Limited
    $GDS
    11/6/2025Outperform
    Macquarie
    Ventyx Biosciences Inc.
    $VTYX
    11/5/2025$18.00Neutral → Buy
    H.C. Wainwright
    EQT Corporation
    $EQT
    10/15/2025Outperform
    William Blair
    EQT Corporation
    $EQT
    8/20/2025$64.00Buy
    Melius
    GDS Holdings Limited
    $GDS
    8/12/2025$48.00Sector Perform → Outperform
    RBC Capital Mkts
    GDS Holdings Limited
    $GDS
    7/16/2025$46.00Neutral → Overweight
    Analyst
    EQT Corporation
    $EQT
    7/8/2025$66.00Outperform
    Mizuho
    EQT Corporation
    $EQT
    7/7/2025$65.00Overweight
    Barclays
    More analyst ratings

    $DUO
    $ELTK
    $EQT
    $ETRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Invus Global Management, Llc was granted 22,400,000 shares, bought $2,000,001 worth of shares (1,538,462 units at $1.30) and was granted 367,145 units of Series B Convertible Preferred Stock (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/4/26 4:25:05 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Gujrathi Sheila bought $300,573 worth of shares (130,000 units at $2.31) (SEC Form 4)

    4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)

    12/26/24 8:05:18 PM ET
    $VTYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO AND PRESIDENT Mohan Raju bought $959,889 worth of shares (500,000 units at $1.92), increasing direct ownership by 30% to 2,175,028 units (SEC Form 4)

    4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)

    11/25/24 9:07:34 PM ET
    $VTYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DUO
    $ELTK
    $EQT
    $ETRN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DUO
    $ELTK
    $EQT
    $ETRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on GDS Holdings

    Macquarie initiated coverage of GDS Holdings with a rating of Outperform

    11/6/25 8:38:06 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    Ventyx Biosciences upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Ventyx Biosciences from Neutral to Buy and set a new price target of $18.00

    11/5/25 7:25:28 AM ET
    $VTYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on EQT Corp.

    William Blair initiated coverage of EQT Corp. with a rating of Outperform

    10/15/25 8:28:19 AM ET
    $EQT
    Oil & Gas Production
    Energy

    $DUO
    $ELTK
    $EQT
    $ETRN
    SEC Filings

    View All

    SEC Form 6-K filed by Eltek Ltd.

    6-K - ELTEK LTD (0001024672) (Filer)

    2/9/26 7:35:31 AM ET
    $ELTK
    Electrical Products
    Technology

    EQT Corporation filed SEC Form 8-K: Leadership Update

    8-K - EQT Corp (0000033213) (Filer)

    2/9/26 6:30:29 AM ET
    $EQT
    Oil & Gas Production
    Energy

    SEC Form FWP filed by Lexicon Pharmaceuticals Inc.

    FWP - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    2/6/26 5:17:30 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DUO
    $ELTK
    $EQT
    $ETRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Eltek Receives Purchase Orders Totaling $12.2 Million

    PETACH TIKVA, Israel, Feb. 9, 2026 /PRNewswire/ -- Eltek Ltd. (NASDAQ:ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today that it received orders totaling $12.2 million from an American defense customer. The products are to be delivered throughout 2026 and 2027 and will subsequently be incorporated as part of a defense project. "We are particularly pleased with this win, as the customer is a U.S.-based client. This aligns with our strategic objective of expanding our presence in the U.S. market with high value-added products," commented Eli Yaffe, CEO of Eltek. About Eltek Eltek – "Innovation Across the Boar

    2/9/26 7:30:00 AM ET
    $ELTK
    Electrical Products
    Technology

    Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

    THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) ("Lexicon") today announced the closing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001, and concurrent private placement of 22,400,000 shares of common stock and 367,145 shares of series b convertible preferred stock (the "Series B Convertible Preferred Stock"). The shares of common stock offered pursuant to the public offering were sold at a public offering price of $1.30 per share and the shares of preferred stock were sold at a price of $65 per share. The offerings closed on February 2, 2026. In addition to the shares s

    2/6/26 5:17:00 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EQT Declares Quarterly Cash Dividend

    PITTSBURGH, Feb. 5, 2026 /PRNewswire/ -- EQT Corporation (NYSE:EQT) today announced that its Board of Directors declared a quarterly cash dividend on its common stock of $0.165 per share, payable on March 2, 2026, to shareholders of record at the close of business on February 17, 2026. Investor ContactCameron HorwitzManaging Director, Investor Relations & [email protected] About EQT CorporationEQT Corporation is a premier, vertically integrated American natural gas company with production and midstream operations focused in the Appalachian Basin. We a

    2/5/26 4:15:00 PM ET
    $EQT
    Oil & Gas Production
    Energy

    $DUO
    $ELTK
    $EQT
    $ETRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Avicenna Life Sci Master Fund Lp claimed ownership of 1,538,462 shares (SEC Form 3)

    3 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/12/26 9:29:24 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHIEF EXECUTIVE OFFICER Stein Michael M covered exercise/tax liability with 15,015 units of Class B Common Stock, decreasing direct ownership by 3% to 538,015 units (SEC Form 4)

    4 - Genie Energy Ltd. (0001528356) (Issuer)

    2/12/26 12:56:06 PM ET
    $GNE
    Power Generation
    Utilities

    CFO Goldin Avi covered exercise/tax liability with 4,220 units of Class B Common Stock, decreasing direct ownership by 4% to 92,271 units (SEC Form 4)

    4 - Genie Energy Ltd. (0001528356) (Issuer)

    2/12/26 12:55:47 PM ET
    $GNE
    Power Generation
    Utilities

    $DUO
    $ELTK
    $EQT
    $ETRN
    Leadership Updates

    Live Leadership Updates

    View All

    Centuri Appoints Nate Tetlow as Vice President of Investor Relations

    Centuri Holdings, Inc. (NYSE:CTRI) ("Centuri" or the "Company"), a leading, North American utility infrastructure services company, today announced the appointment of Nate Tetlow as Vice President of Investor Relations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250825016023/en/Nate Tetlow joins Centuri as Vice President Investor Relations In this new role, Mr. Tetlow will have accountability for Investor Relations, including driving a best-in-class investor relations program and further strengthening relationships with analysts and institutional investors as the Company's primary liaison to the investment community. Mr. T

    8/25/25 8:45:00 AM ET
    $CTRI
    $ETRN
    Oil & Gas Production
    Utilities
    Natural Gas Distribution

    GDS Announces Results of Annual General Meeting of Shareholders

    SHANGHAI, China, June 26, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ:GDS, HKEX: 9698)), a leading developer and operator of high-performance data centers in China, today announced that it held its Annual General Meeting of Shareholders ("2025 AGM") on June 26, 2025. Each of the resolutions submitted to the shareholders for approval at the 2025 AGM has been approved. Specifically, the shareholders of the Company passed ordinary resolutions approving: Re-election of Mr. William Wei Huang as a director of the Company;Re-election of Ms. Bin Yu as a director of the Company;Re-election of Mr. Zulkifli Baharudin as a director of the Company;Co

    6/26/25 7:00:07 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists

    Appointment of seven recognized experts is validating for Ventyx's NLRP3 Program--AD/PD™ 2025 provides helpful insights on potential next steps in Parkinson's disease SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx", "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for autoimmune, inflammatory, and neurodegenerative diseases, today announced the appointment of seven additional internationally-recognized scientists and clinicians to its Scientific Advisory Board (SAB): Mo Lamkanfi, PhD, Luke O'Neill, PhD, Ted Dawson, MD, PhD, Martin Pomper, MD, PhD, Antonio Abbate, MD, PhD, Paul Cremer, MD

    4/1/25 7:00:00 AM ET
    $VTYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DUO
    $ELTK
    $EQT
    $ETRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DUO
    $ELTK
    $EQT
    $ETRN
    Financials

    Live finance-specific insights

    View All

    EQT Declares Quarterly Cash Dividend

    PITTSBURGH, Feb. 5, 2026 /PRNewswire/ -- EQT Corporation (NYSE:EQT) today announced that its Board of Directors declared a quarterly cash dividend on its common stock of $0.165 per share, payable on March 2, 2026, to shareholders of record at the close of business on February 17, 2026. Investor ContactCameron HorwitzManaging Director, Investor Relations & [email protected] About EQT CorporationEQT Corporation is a premier, vertically integrated American natural gas company with production and midstream operations focused in the Appalachian Basin. We a

    2/5/26 4:15:00 PM ET
    $EQT
    Oil & Gas Production
    Energy

    GDS Announces Private Placement of US$300 Million convertible preferred shares to A Chinese Institutional Investor

    SHANGHAI, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ:GDS, HKEX: 9698)), a leading developer and operator of high-performance data centers in China, today announced a private placement of US$300 million of Series B convertible preferred shares (the "convertible preferred shares") to Huatai Capital Investment Limited, a Chinese institutional investor (the "Private Placement"). GDS will use the proceeds from the private placement to fund expansion of its data center capacity and for general corporate purposes. The convertible preferred shares include the following key terms: During the first six years from their issuance da

    1/30/26 8:40:00 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    EQT Corporation Schedules Fourth Quarter and Year-End 2025 Earnings Release and Conference Call

    PITTSBURGH, Jan. 22, 2026 /PRNewswire/ -- EQT Corporation (NYSE:EQT) plans to issue its fourth quarter and year-end 2025 financial and operating results news release after market close on Tuesday, February 17, 2026, and will host a conference call to review the results and other relevant matters on Wednesday, February 18, 2026, beginning at 10:00 a.m. ET. A brief Q&A session for securities analysts will immediately follow the discussion. To access the live audio webcast of the conference call, visit EQT's investor relations website at ir.eqt.com. A replay will be archived and

    1/22/26 4:15:00 PM ET
    $EQT
    Oil & Gas Production
    Energy